Eli Lilly and Co. said on Thursday it has agreed to pay up to $500 million to settle 18,000 Zyprexa lawsuits alleging it had failed to adequately warn patients that Zyprexa may increase the risk of diabetes.
“While we remain confident that these claims are without merit, we took this difficult step because we believe it […]

In June 2005, Eli Lilly and company received a subpoena from Florida attorney general�s office seeking documents on Medicaid-related sales of the company�s Zyprexa and its marketing and promotional practices with respect to the schizophrenia drug. The subpoena came from the Medicaid Fraud Control unit of the state attorney general�s office, the company said in […]

Eli Lilly & Co. said it has agreed to pay $690 million to settle about 8,000 Zyprexa lawsuits pending in the United States, over its alleged failure to provide adequate warning that the drug could increase a patients’ risk for developing diabetes.
“While we believe the claims are without merit, we took this difficult step because […]

A British Columbia man last week filed a class action lawsuit against drug maker Eli Lilly, alleging the company “purposefully minimized and understated health hazards and risks associated with Zyprexa.”
The Plaintiff alleges that his use of Zyprexa resulted in diabetes.
“Eli Lilly, through literature and oral statements, deceived potential users of Zyprexa and their physicians by […]

Florida Medicaid’s new policy will no longer pay for Neurontin, Zyprexa and so-called COX II pain relievers Celebrex, Vioxx and Bextra unless they are prescribed as listed on the U.S. Food and Drug Administration label, the Sun Sentinel reports.
The new policy ends coverage for many “off-label” uses, uses not approved by the FDA, forcing thousands […]

Zyprexa Lawsuits against Eli Lilly and Co. over its blockbuster drug are headed to court in Brooklyn, N.Y.
Lilly’s request to consolidate a growing number of Zyprexa cases in Indiana was denied by a judicial panel on multidistrict litigation in April.
“Obviously we don’t like going to the defendant’s home state” to try the Zyprexa […]

Parker & Waichman, LLP and Douglas & London LLP Monday announced the first nationwide class action lawsuit against Eli Lilly and Company on behalf of all persons residing in the United States who used the atypical antipsychotic drug Zyprexa.
The lawsuit, filed in the U.S. District Court for the Eastern District of New York, seeks relief […]

Eli Lilly and Co. said yesterday the U.S. Attorney’s Office in Pennsylvania is investigating its marketing and promotional practices of certain drugs.
The company said it believes the drugs involved include its schizophrenia drug Zyprexa, its former blockbuster antidepressant drug Prozac, and its osteoporosis drug Evista.
The Indianapolis drug maker said it the outcome of the investigation […]

Parker & Waichman LLP said last week it filed multiple lawsuits against Eli Lilly and Company on behalf of three individuals who claim to have sustained severe side effects from taking the schizophrenia drug Zyprexa.
The firm said two of the plaintiffs have been diagnosed with serious cases of diabetes, and another plaintiff has required lengthy […]

The U.S. Food and Drug Administration has asked the makers of six atypical antipsychotic drugs to update product labeling to include a warning about a possible link with diabetes, The Associated Press reported. The atypical antipsychotic drugs includes Zyprexa by Eli Lilly & Co., Clozaril by Novartis, Risperdal by Janssen, Seroquel by AstraZeneca, Geodon by […]